Frontier Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-11,609
| Closed | -$498K | – | 323 |
|
|
2017
Q3 | $498K | Sell |
11,609
-82,873
| -88% | -$3.56M | ﹤0.01% | 283 |
|
|
2017
Q2 | $3.5M | Sell |
94,482
-8,081
| -8% | -$299K | 0.03% | 279 |
|
|
2017
Q1 | $5.55M | Sell |
102,563
-1,817
| -2% | -$98.4K | 0.04% | 268 |
|
|
2016
Q4 | $5.54M | Sell |
104,380
-2,758
| -3% | -$146K | 0.04% | 259 |
|
|
2016
Q3 | $6.49M | Sell |
107,138
-16,847
| -14% | -$1.02M | 0.05% | 261 |
|
|
2016
Q2 | $8.16M | Sell |
123,985
-18,596
| -13% | -$1.22M | 0.07% | 249 |
|
|
2016
Q1 | $8.08M | Sell |
142,581
-13,132
| -8% | -$745K | 0.06% | 252 |
|
|
2015
Q4 | $36.6M | Sell |
155,713
-77,534
| -33% | -$18.2M | 0.3% | 116 |
|
|
2015
Q3 | $36.9M | Buy |
233,247
+66,858
| +40% | +$10.6M | 0.31% | 117 |
|
|
2015
Q2 | $62.9M | Buy |
166,389
+122,620
| +280% | +$46.4M | 0.45% | 69 |
|
|
2015
Q1 | $18.3M | Sell |
43,769
-34,939
| -44% | -$14.6M | 0.13% | 225 |
|
|
2014
Q4 | $21.5M | Buy |
78,708
+14,854
| +23% | +$4.07M | 0.16% | 194 |
|
|
2014
Q3 | $12.4M | Buy |
63,854
+2,328
| +4% | +$453K | 0.1% | 235 |
|
|
2014
Q2 | $15.1M | Buy |
+61,526
| New | +$15.1M | 0.11% | 225 |
|